Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:32 PM
Ignite Modification Date:
2025-12-24 @ 6:32 PM
NCT ID:
NCT01171157
Eligibility Criteria:
Inclusion Criteria:
* Subjects who the investigator believes that they can and will comply with the requirements of the protocol.
* A male or female \>= 65 years of age.
* Written informed consent obtained from the subject.
* Presenting within the first 72 hours of an influenza-like illness. Influenza-like illness is defined as the presence of:
* Fever measured by the patient or physician and at least one of the following symptoms:
* Sore throat.
* Coryza (runny nose) and/or nasal congestion.
* Cough.
* Availability to be followed up by phone or in person after an interval of approximately 14 - 21 days.
Exclusion Criteria:
* Receipt of any experimental influenza vaccine within 6 months of the onset of the influenza-like illness.
* Terminal stage of disease.
* Subjects living in a nursing home.
* Use of any investigational or non-registered product planned during the study period.
* Subjects who have already been enrolled in this study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Study:
NCT01171157
Study Brief:
Protocol Section:
NCT01171157